Based on the present data from a prospective exploratory imaging trial, we could demonstrate a strong association between IL-6 plasma levels and PET imaging-derived tumor hypoxia dynamics in patients undergoing chemoradiation for locally advanced HNSCC. Here, IL6 is linked to head and neck squamous cell carcinoma.